首页> 外国专利> METHOD FOR PREDICTING THE PROGRESS OF PAPILLOMAVIRUS INFECTION IN PATIENTS WITH CHRONIC RECURRENT INFLUENZA ASSOCIATED CERVICITIS

METHOD FOR PREDICTING THE PROGRESS OF PAPILLOMAVIRUS INFECTION IN PATIENTS WITH CHRONIC RECURRENT INFLUENZA ASSOCIATED CERVICITIS

机译:预测慢性复发性感染相关性宫颈炎患者乳头瘤病毒感染进展的方法

摘要

FIELD: medicine.;SUBSTANCE: invention relates to medicine, namely to gynecology, and can be used in gynecological hospitals and outpatient settings of women's clinics and polyclinics to predict the progress of papillomavirus infection in patients with chronic recurrent HPV-associated cervicitis. Summary of invention: patient is determined genotypes of polymorphisms Ser249Pro in the gene TLR6 and Pro72Arg in the gene TP53 and when a patient identifies a Ser allele in the TLR6 gene and the homozygous genotype Pro/Pro or Arg/Arg in the TP53 gene, a low risk of progression of the PVI is predicted; if Pro/Pro mutation in TLR6 gene or the heterozygous Pro/Arg genotype in the TP53 gene is detected in the patient, the average risk of progression of the PVI is predicted; when patient is identified, Pro/Pro mutations in TLR6 gene and heterozygous Pro/Arg genotype in the TP53 gene predict a high risk of progression of the PVI.;EFFECT: invention allows to predict progress of PID in a patient with HPV-associated cervicitis with a high degree of reliability, which will allow choosing the right tactics of management.;1 cl, 5 tbl, 3 ex
机译:技术领域本发明涉及医学,即妇科,并且可以在妇科医院和妇女诊所和综合诊所的门诊环境中用于预测慢性复发性HPV相关性宫颈炎患者中乳头瘤病毒感染的进展。发明概述:确定患者基因TP53中TLR6和Pro72Arg基因多态性Ser249Pro的基因型,以及当患者鉴定TLR6基因中Ser等位基因和TP53基因中纯合子基因Pro / Pro或Arg / Arg时,预测PVI进展的风险低;如果在患者中检测到TLR6基因的Pro / Pro突变或TP53基因的杂合Pro / Arg基因型,则可以预测PVI进展的平均风险;当确定患者时,TLR6基因的Pro / Pro突变和TP53基因的杂合Pro / Arg基因型预示着PVI进展的高风险。效果:本发明可以预测HPV相关性宫颈炎患者的PID进展具有高度的可靠性,这将使您可以选择正确的管理策略。; 1 cl,5 tbl,3 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号